HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 198 filers reported holding HERON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,592 | +77.6% | 6,400 | +100.0% | 0.00% | – |
| Q2 2023 | $3,712 | +75.6% | 3,200 | +128.6% | 0.00% | – |
| Q1 2023 | $2,114 | -39.6% | 1,400 | 0.0% | 0.00% | – |
| Q4 2022 | $3,500 | -41.7% | 1,400 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $6,000 | +50.0% | 1,400 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -50.0% | 1,400 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $8,000 | -38.5% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $13,000 | -13.3% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $15,000 | -31.8% | 1,400 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $22,000 | -4.3% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $23,000 | -23.3% | 1,400 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $30,000 | +42.9% | 1,400 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $21,000 | 0.0% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $21,000 | +31.2% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $16,000 | – | 1,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |